Pyxis Oncology, Inc. SEC filings PYXS
Pyxis Oncology, Inc. has 354 filings in SEC EDGAR's recent list, going back to Jul 12, 2019. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 1, 2026 (material agreement, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| DEF 14A | Proxy statement | Oct 21, 2026 | Oct 21, 2026 |
| PRE 14A | Preliminary proxy statement | Oct 9, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 1, 2026 | Sep 29, 2026 |
| 424B5 | Prospectus supplement | Oct 1, 2026 | — |
| 424B5 | Prospectus supplement | Sep 29, 2026 | — |
| 424B5 | Prospectus supplement | Sep 29, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2026 | Sep 9, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 8, 2026 | Sep 3, 2026 |
| 424B2 | Prospectus | Aug 28, 2026 | — |
| EFFECT | Filing | Aug 27, 2026 | — |
| S-3 | Shelf registration | Aug 20, 2026 | — |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 2, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 15, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| ARS | Annual report to shareholders | Apr 30, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2026 | — |
| DEF 14A | Proxy statement | Apr 30, 2026 | Apr 30, 2026 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 30, 2026 | Feb 6, 2026 |
| S-8 | Employee stock plan registration | Mar 23, 2026 | — |
| 10-K | Annual report | Mar 23, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 23, 2026 | Mar 23, 2026 |
| 8-K | Current report | Feb 6, 2026 | Feb 6, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 18, 2025 | Dec 18, 2025 |
| EFFECT | Filing | Dec 9, 2025 | — |
| CORRESP | Letter to the SEC | Dec 8, 2025 | — |
| S-3 | Shelf registration | Nov 26, 2025 | — |
| 10-Q | Quarterly report | Nov 3, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2025 | Nov 3, 2025 |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Other events
|
Aug 4, 2025 | Aug 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Jul 3, 2025 | Jul 1, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 18, 2025 |
| 10-Q | Quarterly report | May 15, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2025 | May 15, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2025 | Mar 24, 2025 |
| S-8 | Employee stock plan registration | Mar 18, 2025 | — |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Officer or director change, Regulation FD disclosure
|
Mar 18, 2025 | Mar 18, 2025 |
| 8-K |
Current report
Other events
|
Feb 26, 2025 | Feb 26, 2025 |
| 8-K |
Current report
Other events
|
Feb 4, 2025 | Feb 4, 2025 |
| 8-K |
Current report
Other events
|
Dec 19, 2024 | Dec 19, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2024 | Nov 20, 2024 |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Oct 23, 2024 | Oct 23, 2024 |
| DEF 14A | Proxy statement | Sep 25, 2024 | Sep 25, 2024 |
| PRE 14A | Preliminary proxy statement | Sep 13, 2024 | Sep 13, 2024 |
| 10-Q | Quarterly report | Aug 14, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2024 | Aug 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jun 10, 2024 | Jun 10, 2024 |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 14, 2024 | May 14, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 11, 2024 |
| 424B2 | Prospectus | Apr 4, 2024 | — |
| EFFECT | Filing | Apr 3, 2024 | — |
| CORRESP | Letter to the SEC | Apr 1, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 29, 2024 | — |
| S-3 | Shelf registration | Mar 27, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 27, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Other events
|
Mar 27, 2024 | Mar 27, 2024 |
| S-8 | Employee stock plan registration | Mar 22, 2024 | — |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 13, 2024 | Mar 12, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Feb 28, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 28, 2023 | Nov 27, 2023 |
| 10-Q | Quarterly report | Nov 7, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K/A | Amended current report | Oct 27, 2023 | Aug 23, 2023 |
| UPLOAD | Letter from the SEC | Sep 6, 2023 | — |
| CORRESP | Letter to the SEC | Aug 28, 2023 | — |
| EFFECT | Filing | Aug 24, 2023 | — |
| S-8 POS | Form s-8 pos | Aug 23, 2023 | — |
| POS AM | Form pos am | Aug 23, 2023 | — |
| S-8 | Employee stock plan registration | Aug 23, 2023 | — |
| 8-K |
Current report
Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
|
Aug 23, 2023 | Aug 23, 2023 |
| UPLOAD | Letter from the SEC | Aug 16, 2023 | — |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 425 | Filing | Aug 11, 2023 | — |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 425 | Filing | Aug 11, 2023 | — |
| 8-K |
Current report
Other events
|
Aug 11, 2023 | Aug 11, 2023 |
| EFFECT | Filing | Jun 30, 2023 | — |
| 425 | Filing | Jun 30, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Jun 30, 2023 | Jun 28, 2023 |
| 424B3 | Prospectus | Jun 30, 2023 | — |
| CORRESP | Letter to the SEC | Jun 29, 2023 | — |
| S-4/A | Form s-4/a | Jun 29, 2023 | — |
| UPLOAD | Letter from the SEC | Jun 15, 2023 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2023 | Jun 13, 2023 |
| S-4 | Registration for a merger or exchange | Jun 8, 2023 | — |
| 425 | Filing | May 30, 2023 | — |
| 425 | Filing | May 25, 2023 | — |
| 425 | Filing | May 24, 2023 | — |
| 425 | Filing | May 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
May 24, 2023 | May 24, 2023 |
| 425 | Filing | May 24, 2023 | — |
| 425 | Filing | May 24, 2023 | — |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure, Other events
|
May 24, 2023 | May 23, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 11, 2023 | May 11, 2023 |
| 10-K/A | Amended annual report | May 10, 2023 | Dec 31, 2022 |
| ARS | Annual report to shareholders | Apr 28, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2023 | — |
| DEF 14A | Proxy statement | Apr 28, 2023 | Jun 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 28, 2023 | Mar 28, 2023 |
| S-8 | Employee stock plan registration | Mar 22, 2023 | — |
| 10-K | Annual report | Mar 22, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 16, 2023 | Mar 16, 2023 |
| 8-K |
Current report
Other events
|
Dec 1, 2022 | Dec 1, 2022 |
| EFFECT | Filing | Nov 14, 2022 | — |
| CORRESP | Letter to the SEC | Nov 10, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2022 | — |
| S-3 | Shelf registration | Nov 1, 2022 | — |
| 10-Q | Quarterly report | Nov 1, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2022 | Nov 1, 2022 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Oct 7, 2022 | Oct 6, 2022 |
| 10-Q | Quarterly report | Aug 15, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Officer or director change
|
Aug 9, 2022 | Aug 3, 2022 |
| S-8 | Employee stock plan registration | Jul 1, 2022 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 13, 2022 |
| 10-Q | Quarterly report | May 13, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 13, 2022 | May 13, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 13, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 14, 2022 | Apr 8, 2022 |
| S-8 | Employee stock plan registration | Mar 29, 2022 | — |
| 10-K | Annual report | Mar 29, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations, Other events
|
Mar 29, 2022 | Mar 29, 2022 |
| 10-Q | Quarterly report | Nov 15, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 15, 2021 | Nov 15, 2021 |
| S-8 | Employee stock plan registration | Oct 22, 2021 | — |
| 424B4 | Prospectus | Oct 8, 2021 | — |
| EFFECT | Filing | Oct 7, 2021 | — |
| S-1MEF | Filing | Oct 7, 2021 | — |
| SEC STAFF LETTER | Filing | Oct 7, 2021 | — |
| S-1/A | Amended registration statement | Oct 7, 2021 | — |
| CERT | Filing | Oct 6, 2021 | — |
| 8-A12B | Filing | Oct 5, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| CORRESP | Letter to the SEC | Oct 5, 2021 | — |
| S-1/A | Amended registration statement | Oct 4, 2021 | — |
| S-1/A | Amended registration statement | Oct 1, 2021 | — |
| CORRESP | Letter to the SEC | Sep 28, 2021 | — |
| S-1 | Registration statement | Sep 17, 2021 | — |
| SEC STAFF LETTER | Filing | Sep 17, 2021 | — |
| DRS/A | Filing | Sep 10, 2021 | — |
| DRSLTR | Filing | Sep 9, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 18, 2021 | — |
| DRSLTR | Filing | Aug 4, 2021 | — |
| DRS/A | Filing | Aug 4, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2021 | — |
| DRS | Filing | Jun 21, 2021 | — |
| D | Filing | Mar 22, 2021 | — |
| D | Filing | Jul 12, 2019 | — |
Showing 167 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- PYXS (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1782223
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.